Bioventus (BVS) Stock Price
$10.01 0.6%
to add to portfolio
AI Score
-
Alternative
4 -
Fundamental
3 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Bioventus, AI stock picks, stock alerts and much more.
BVS AI Stock Analysis
AI stock analysis for BVS is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Bioventus (BVS) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Bioventus (BVS) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Bioventus (BVS), currently trading at $10.01, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About BVS
-
Bioventus Inc.
-
Symbol
BVS
-
Market
NASDAQ
-
Industry
Medical - Devices
-
Market Cap
654.3M
Similar Stocks
 |
Align Technology ALGN |
$190.4 3.9% |
5 |
 |
iRhythm Technologies IRTC |
$119.4 6% |
6 |
 |
Cutera CUTR |
$0.43 5.3% |
4 |
 |
Dexcom DXCM |
$88.78 0.6% |
5 |
 |
Bruker BRKR |
$50.82 4% |
5 |
News
BVS Alternative Data
Web Traffic
Bioventus receives an estimated 10135 monthly visitors to bioventus.com.
-
Web Traffic
10135
-
Change from Previous Month
15.3%
-
3 Month Change
15.2%
-
YoY Change
15.2%
Reddit Mentions
Bioventus has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
News Mentions
Bioventus was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
100%
-
3 Month Change
0%
Twitter Followers
Bioventus has 1,859 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.1% over the last month.
-
Twitter Followers
1859
-
Daily Change
0.1%
-
1 Month Change
0.1%
-
3 Month Change
2.4%
-
YoY Change
2.4%
Facebook Engagement
Bioventus has engaged 0 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
100%
-
YoY Change
100%
Instagram Followers
Bioventus has 667 Instagram Followers on its main Instagram account, up by 1.2% over the last month.
-
Instagram Followers
667
-
Daily Change
0%
-
1 Month Change
1.2%
-
3 Month Change
4.2%
-
YoY Change
4.2%
Youtube Subscribers
Bioventus has 24,900 subscribers on its main Youtube channel, up by 0.4% over the last month.
-
Youtube Subscribers
24900
-
Daily Change
0%
-
1 Month Change
0.4%
-
3 Month Change
1.6%
-
YoY Change
1.6%
LinkedIn Followers
39,930 are following Bioventus on LinkedIn, up by 1.7% over the last month.
-
LinkedIn Followers
39930
-
Daily Change
0.1%
-
1 Month Change
1.7%
-
3 Month Change
4.1%
Job Postings
Bioventus currenly has an estimated 63 open job postings, up by 16.7% over the last month.
-
Job Postings
63
-
Daily Change
1.6%
-
1 Month Change
16.7%
-
3 Month Change
53.7%
-
YoY Change
53.7%
LinkedIn Employees
According to LinkedIn, Bioventus has 1,110 employees, down by -0.1% over the last month.
-
LinkedIn Employees
1110
-
Daily Change
0%
-
1 Month Change
0.1%
-
3 Month Change
9.8%
-
YoY Change
9.8%
Business Outlook
-
Business Outlook
49
-
Change from Previous Month
7.5%
-
3 Month Change
0%
-
YoY Change
0%
BVS Financials
BVS Key Metrics
-
Total Revenue
$139M
-
Net Income
-$4.8M
-
Earnings per Share
-$0.0739
-
Free cash flow
$12.1M
-
EBITDA
$50.7M
-
EBITDA Ratio
0.364915
-
Total Assets
$769.5M
BVS 2-year Revenue & Income
BVS 2-year Free Cash Flow
BVS Technicals
BVS SMA
BVS RSI
FAQ
What's the current price of Bioventus (BVS) Stock?
The price of an Bioventus (BVS) share is $10.01.
What's the market cap of Bioventus?
The current market cap of Bioventus is 654.3M.
Should I buy or sell BVS?
Bioventus shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Bioventus is better viewed as a hold or accumulate position while waiting for further developments.
Is Bioventus a good investment?
The current analysis of Bioventus' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Bioventus' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Bioventus (BVS) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Bioventus stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Bioventus (BVS) that investors often compare it to?
Bioventus (BVS) is often compared to similar stocks such as Align Technology, iRhythm Technologies, Cutera, Dexcom and Bruker.
What is the forecast for Bioventus' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Bioventus' stock price to be around $9.66 in 2026. Starting from the current price of $10.01, this represents a 3.5% change in price, indicating a neutral outlook for the stock.
How to buy Bioventus (BVS) Stock?
Bioventus stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Bioventus shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.